Early Start to MS Therapy Boosts Long-Term Results

Starting treatment for multiple sclerosis when the first suggestive neurologic event occurred led to better outcomes in disease progression and long-term cognitive function, compared with patients whose initial treatment was deferred, based on findings from 5-year follow-up of randomized treatment in 358 patients.